Login / Signup
Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-It depends on how you use the drug. Authors' reply.
Bernd Bokemeyer
Sandra Plachta-Danielzik
Published in:
Alimentary pharmacology & therapeutics (2023)
Keyphrases
</>
ulcerative colitis
adverse drug
drug induced
patients with inflammatory bowel disease